1-2 of 2
Hidenori Nakajima
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4350: Low frequencies of SF3B1 mutations indicate SF3B1 inhibitor as a novel moleculartargeted drug for colorectal cancer.

Free
Tomoki Yamano, Hidenori Nakajima, Satoshi Tsuda, Shuji Kubo, Mie Hamanaka, Masayoshi Kobayashi, Daisuke Yamagishi, Takashi Kuno, Kiyoshi Tsukamoto, Astuko Tamamoto, Masafumi Noda, Nagahide Matsubara, Dave SB Hoon, Naohiro Tomita
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4350.
https://doi.org/10.1158/1538-7445.AM2013-4350
Published: 15 April 2013
View articletitled, Abstract 4350: Low frequencies of SF3B1 mutations indicate SF3B1 inhibitor as a novel moleculartargeted drug for colorectal cancer.
Journal Articles

FK228 (Depsipeptide) as a Natural Prodrug That Inhibits Class I Histone Deacetylases

Free
Ryohei Furumai, Akihisa Matsuyama, Nobuyuki Kobashi, Kun-Hyung Lee, Makoto Nishiyama, Hidenori Nakajima, Akito Tanaka, Yasuhiko Komatsu, Norikazu Nishino, Minoru Yoshida, Sueharu Horinouchi
Journal: Cancer Research
Cancer Res (2002) 62 (17): 4916–4921.
Published: 01 September 2002
View articletitled, FK228 (Depsipeptide) as a Natural Prodrug That Inhibits Class I Histone Deacetylases
Open the PDF for FK228 (Depsipeptide) as a Natural Prodrug That Inhibits Class I Histone Deacetylases in another window